@AICp26,000 posts for what?
I've told you before - but you really don't have to take my word for it because you can look up the history of my IMU postings, its all there in black and white - I bought into IMU in 2019 at around 3c. So even if I had been too stupid to sell any on its run up to 60c and now its run down to 10c, I'd still be way in the money. Of course I did sell the majority of my stake in that range and again, you can look at all of my posts where I tell similar posters to yourself that:
1. IMU has been a highly profitable stock for me.
2. Any remaining shares I have are free carried.
3. Even though I don't rate the company any longer, I am not too arrogant to think that I could be wrong and that holding the few I have remaining is like holding a lottery ticket - you don't really expect to win, but you're not just going to throw out the ticket before the draw.
The bit that you and so many others can't get your head around is that making profits from IMU was either good luck or good management on my part - nothing to do with the company. I was smart enough or lucky enough to trade it successfully. I made my money from other investors who were silly enough or unlucky enough to have traded it unsuccessfully. Just like anyone else that has made money from IMU - purely down to smart or lucky trading. Literally nothing to do with Hopper, Chong and co.
Its hard (seemingly impossible?) for you to understand that the quality of a company, its products, its management team, is completely independent of the success or otherwise that an individual investor has had in trading the stock. Do yourself a favour and have another read of that sentence.
To date, the company has been a failure. It has taken in several hundred million dollars of investment and failed to return anything to shareholders in any form.
"Patience, patience, CF33 may cure cancer and then by the brilliance of its researchers and the brilliance of if insightful chairman and clinical-trial-guru CEO, it will return multi-bags to investors regardless of what price they paid" .... maybe. My view is that that chance would be enhanced with a different Chair / CEO / BP liaison. Axel Hoos for instance.
And as for those idiotic posters who somehow think that criticising IMU is the same as not wanting a cure for cancer - consider this. Since listing over a decade ago, IMU has burnt through several hundred million dollars and gone backwards from Phase II trials to Phase I trials. It is further away from a registrational trial and hence the commercialisation of a cancer treatment than it was a decade ago. Is it possible that we'd be closer to a cancer treatment if that money had been invested in one of the several thousand other companies pursuing cancer treatments?
(20min delay)
